Receipt of in-principle / prior approval from BSE for issuance and allotment of 1770710 equity shares of INR 5 each at a price not less than INR 42 each to promoter against conversion of ....

SAMPRE NUTRITIONS LIMITED CIN: L15499TG1991PLC013515 Date: 29 August 2026 BSE Limited 2nd Floor, New Trading Wing, Rotunda Building, P.J. Towers, Dalal Street, Fort, Mumbai - 400001, MH Subject: Intimation of receipt of the In-Principal approval from BSE Limited for Issue of Equity Shares to Promoter and Promoter Group Category on a Preferential Basis Reference: BSE Symbol: SAMPRE; BSE Scrip Code: 530617 Sir / Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, (“Listing Regulations”) we would like to inform that Sampre Nutritions Limited (“the Company”) has received the in-principal / prior approval for issue of equity shares via conversion of unsecured loans vide letter ref: LOD/PREF/KS/FIP/726/2026-27, dated 28 August 2026 to be issued to promoter and promoter group category for consideration on a preferential basis. Please find enclosed herewith a copy of the In-Principle / Prior Approval of the BSE Limited. Kindly take the above information on record and acknowledge the receipt of the same. Thanking You. Sincerely, For Sampre Nutritions Limited Brahma Gurbani Managing Director (DIN: 00318180) Enclosed: As above Regd. Off & Works: Unit-1: Plot No. 133, I.E, Medchal - 501401, Telangana, India. Ph: +91-8418-222428 Unit-2: Plot No. 127, 128, Royes Building, I.E. Medchal, Malkajgiri - 501401, Telangana. e-mail: gurbani@gurbanigroup.in, bkgurbani@gurbanigroup.in, www.gurbanigroup.in